This issue features coverage from the ASH Meeting on Hematologic Malignancies that took place in Chicago, IL. Our feature on big data reveals its potential to revolutionize healthcare, and our Editor's Corner gives an in-depth look at putting together a presentation for the upcoming ASH Annual Meeting.
In this issue, we look at the problem of physician burnout, follow a day in the life of a hem/onc APP, and examine the work-life spectrum.
This month, we take a behind-the-scenes look at guideline development, debate the length of anticoagulation for cancer-associated thrombosis, and report on the latest hematologic research from the American Society of Clinical Oncology annual meeting and the International Society on Thrombosis and Haemostasis 2015 Congress.
This month, we uncover the potential pitfalls of precision medicine, report on the latest hematologic research from the American Society of Clinical Oncology annual meeting and European Hematology Association Congress, and more.
This month, we take an in-depth look at the work that hematology advocates are doing, the latest research from Blood, and the latest hematology/oncology news.
This issue features a look at new tactics for fighting the cancer drug pricing bloat, a debate on fludarabine in CLL, a report from ASH’s Sickle Cell Disease Summit, and more.
This issue features a look at the ACA’s out-of-pocket limit, reports from the IOM’s Pediatric Oncology Workshop, tips for improving your presentations, and more.
This issue features a debate of rituximab versus splenectomy in ITP patients, a look at novel oral anticoagulants taking warfarin’s place, mentoring advice from a fellowship program director, and more.
This issue features ABIM's update to MOC, the endocrinologist's perspective on diabetes management, an analysis of the Choosing Wisely program, and more.
A special edition featuring drug updates from the 2014 ASH Annual Meeting.